Senate Battle Lies Ahead For FDA Nominee

Law360, New York (September 21, 2006, 12:00 AM EDT) -- President Bush's pick to lead the U.S. Food and Drug Administration has finally won approval from a crucial Senate committee, but doubt lingers over whether he can win confirmation from the full Senate.

On Wednesday, the Senate Health, Education, Labor and Pensions Committee endorsed the nomination of Andrew von Eschenbach, who has been serving as the acting FDA commissioner since last year.

"We need a strong leader at the FDA right now, one who has a mandate to act," said Sen. Mike Enzi (R-Wyo.), the committee...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.